Tin tức & Cập nhật

Pharmacists working in hospitals do not see themselves competent enough to handle cancer patients, a study has shown.

In the phase II VESPER-2 trial, the investigational injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA) berobenatide shows robust reductions in weight and HbA1c in adults with obesity/overweight and type 2 diabetes (T2D).

Treatment with secukinumab helps reduce symptoms and disease activity in Chinese children with enthesitis-related arthritis, as shown in a retrospective study.

Exposure to several glucose-lowering drugs appears to have a protective effect on the risk of depression in individuals with type 2 diabetes (T2D), according to a population-based cohort study in Hong Kong.

Treatment with ocrelizumab helps delay progression of disability, especially of the upper limb, in a broad population of patients with primary progressive multiple sclerosis (PPMS), including those who are older and have more advanced disease, according to the phase 3b ORATORIO-HAND trial.

Supplementation with vitamin K homologue menaquinone-7 (MK-7) for 2 years appears to reduce plaque calcification in patients with symptomatic coronary artery disease, as shown in a study.

Treatment with inhaled treprostinil helps preserve lung function and delay disease progression in patients with idiopathic pulmonary fibrosis (IPF), according to phase 3 data from the TETON-1 trial.